Financial Ratios Terumo Corporation
Equities
4543
JP3546800008
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,342.50 JPY | +2.11% |
|
+20.13% | +3.19% |
| 18/05 | Japan's Nikkei slips for third day as global bond selloff, Mideast war weigh | RE |
| 15/05 | Terumo's Profit Rises 16% Fiscal Year 2025 | MT |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.7 | 5.16 | 4.87 | 5.12 | 6.25 | |||||
Return on Total Capital | 5.58 | 6.02 | 5.65 | 5.91 | 7.19 | |||||
Return On Equity % | 9.58 | 9.5 | 8.41 | 8.73 | 8.68 | |||||
Return on Common Equity | 9.59 | 9.5 | 8.41 | 8.73 | 8.68 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 53.21 | 52.52 | 50.89 | 52.18 | 54.11 | |||||
SG&A Margin | 26.13 | 25.42 | 26.2 | 37.28 | 36.71 | |||||
EBITDA Margin % | 24.66 | 24.96 | 23.17 | 21.44 | 23.65 | |||||
EBITA Margin % | 15.87 | 16.59 | 14.61 | 17.36 | 19.64 | |||||
EBIT Margin % | 15.87 | 16.59 | 14.61 | 15.25 | 17.65 | |||||
Income From Continuing Operations Margin % | 12.58 | 12.63 | 10.89 | 11.54 | 11.29 | |||||
Net Income Margin % | 12.59 | 12.63 | 10.89 | 11.54 | 11.29 | |||||
Net Avail. For Common Margin % | 12.59 | 12.63 | 10.89 | 11.54 | 11.29 | |||||
Normalized Net Income Margin | 10.01 | 10.36 | 9.16 | 9.59 | 10.84 | |||||
Levered Free Cash Flow Margin | 1.34 | 4.87 | 3.66 | 0.88 | 12.97 | |||||
Unlevered Free Cash Flow Margin | 1.56 | 5.02 | 3.83 | 1.02 | 13.09 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.47 | 0.5 | 0.53 | 0.54 | 0.57 | |||||
Fixed Assets Turnover | 2.18 | 2.22 | 2.33 | 2.34 | 2.45 | |||||
Receivables Turnover (Average Receivables) | 4.71 | 5.31 | 5.72 | 5.87 | 6.12 | |||||
Inventory Turnover (Average Inventory) | 1.78 | 1.79 | 1.8 | 1.64 | 1.64 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.48 | 3.14 | 2.8 | 1.9 | 3 | |||||
Quick Ratio | 1.56 | 1.92 | 1.56 | 1.02 | 1.67 | |||||
Operating Cash Flow to Current Liabilities | 0.57 | 0.8 | 0.54 | 0.39 | 0.87 | |||||
Days Sales Outstanding (Average Receivables) | 77.45 | 68.7 | 63.78 | 62.36 | 59.63 | |||||
Days Outstanding Inventory (Average Inventory) | 205.06 | 204.44 | 203.03 | 222.6 | 222.98 | |||||
Average Days Payable Outstanding | 99.2 | 84.4 | 72.08 | 40.16 | 38.4 | |||||
Cash Conversion Cycle (Average Days) | 183.31 | 188.74 | 194.73 | 244.79 | 244.21 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 34.21 | 25.59 | 24 | 20.24 | 15.63 | |||||
Total Debt / Total Capital | 25.49 | 20.37 | 19.36 | 16.83 | 13.52 | |||||
LT Debt/Equity | 28.56 | 24.91 | 22.38 | 7.86 | 13.99 | |||||
Long-Term Debt / Total Capital | 21.28 | 19.83 | 18.05 | 6.54 | 12.1 | |||||
Total Liabilities / Total Assets | 36.6 | 31.31 | 30.65 | 27.54 | 25.15 | |||||
EBIT / Interest Expense | 44.05 | 71.22 | 53.72 | 68.07 | 90.73 | |||||
EBITDA / Interest Expense | 68.43 | 107.17 | 85.22 | 98.89 | 125.2 | |||||
(EBITDA - Capex) / Interest Expense | 40.26 | 74.5 | 61.58 | 69.48 | 91.16 | |||||
Total Debt / EBITDA | 1.94 | 1.48 | 1.4 | 1.32 | 0.85 | |||||
Net Debt / EBITDA | 0.61 | 0.31 | 0.42 | 0.3 | -0.03 | |||||
Total Debt / (EBITDA - Capex) | 3.29 | 2.12 | 1.94 | 1.87 | 1.16 | |||||
Net Debt / (EBITDA - Capex) | 1.04 | 0.44 | 0.58 | 0.43 | -0.04 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -2.39 | 14.57 | 16.62 | 12.39 | 12.4 | |||||
Gross Profit, 1 Yr. Growth % | -5.03 | 13.08 | 13 | 15.25 | 16.55 | |||||
EBITDA, 1 Yr. Growth % | -6.68 | 15.97 | 8.25 | 12.02 | 23.96 | |||||
EBITA, 1 Yr. Growth % | -11.29 | 19.73 | 2.68 | 12.4 | 27.18 | |||||
EBIT, 1 Yr. Growth % | -11.29 | 19.73 | 2.68 | 13.48 | 30.13 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -9.22 | 15.04 | 0.58 | 19.09 | 9.97 | |||||
Net Income, 1 Yr. Growth % | -9.32 | 14.94 | 0.58 | 19.09 | 9.97 | |||||
Normalized Net Income, 1 Yr. Growth % | -9.38 | 18.53 | 3.07 | 15.57 | 27.14 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -9.33 | 14.95 | 1.34 | 20.16 | 10.52 | |||||
Accounts Receivable, 1 Yr. Growth % | -2.25 | 5.61 | 10.76 | 17.88 | -0.8 | |||||
Inventory, 1 Yr. Growth % | 19.32 | 13.08 | 25.73 | 14.82 | 2.72 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 13.34 | 11.41 | 11.08 | 12.13 | 3.66 | |||||
Total Assets, 1 Yr. Growth % | 8.85 | 9.07 | 8.72 | 14.3 | -0.16 | |||||
Tangible Book Value, 1 Yr. Growth % | 31.2 | 29.28 | 15.14 | 27.59 | 9.44 | |||||
Common Equity, 1 Yr. Growth % | 13.49 | 18.17 | 9.75 | 19.44 | 3.12 | |||||
Cash From Operations, 1 Yr. Growth % | 3.41 | 16.45 | -16.92 | 24.5 | 44.06 | |||||
Capital Expenditures, 1 Yr. Growth % | 0 | -14.13 | -1.53 | 15.24 | 12.99 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -73.83 | 317.92 | -12.35 | -70.36 | 1.57T | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -70.49 | 268.32 | -10.95 | -67.29 | 1.35T | |||||
Dividend Per Share, 1 Yr. Growth % | 3.57 | 17.24 | 17.65 | 10 | 18.18 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 1.19 | 5.75 | 15.59 | 14.49 | 12.4 | |||||
Gross Profit, 2 Yr. CAGR % | 0.02 | 3.63 | 13.04 | 14.12 | 15.9 | |||||
EBITDA, 2 Yr. CAGR % | 1.33 | 4.03 | 12.04 | 6.33 | 17.84 | |||||
EBITA, 2 Yr. CAGR % | -2.92 | 3.06 | 10.88 | 17.46 | 19.56 | |||||
EBIT, 2 Yr. CAGR % | -2.92 | 3.06 | 10.88 | 10.1 | 21.52 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -1.32 | 2.2 | 7.57 | 9.44 | 14.44 | |||||
Net Income, 2 Yr. CAGR % | -1.4 | 2.09 | 7.52 | 9.44 | 14.44 | |||||
Normalized Net Income, 2 Yr. CAGR % | -2.39 | 3.64 | 10.53 | 11.13 | 21.22 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -1.37 | 2.1 | 7.93 | 10.35 | 15.24 | |||||
Accounts Receivable, 2 Yr. CAGR % | 0.12 | 1.61 | 8.16 | 11.79 | 8.14 | |||||
Inventory, 2 Yr. CAGR % | 14.42 | 16.16 | 19.24 | 20.15 | 8.6 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 21.81 | 12.37 | 11.25 | 11.6 | 7.81 | |||||
Total Assets, 2 Yr. CAGR % | 9.8 | 8.96 | 8.89 | 11.48 | 6.82 | |||||
Tangible Book Value, 2 Yr. CAGR % | 29.59 | 30.24 | 22.01 | 27.2 | 18.17 | |||||
Common Equity, 2 Yr. CAGR % | 10.78 | 15.81 | 13.88 | 14.5 | 10.98 | |||||
Cash From Operations, 2 Yr. CAGR % | 13.94 | 9.74 | -1.64 | 1.7 | 33.92 | |||||
Capital Expenditures, 2 Yr. CAGR % | 25.88 | -7.33 | -8.04 | 6.53 | 14.11 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -49.13 | 4.58 | 91.39 | - | 122.17 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -46.08 | 4.25 | 81.11 | - | 117.7 | |||||
Dividend Per Share, 2 Yr. CAGR % | 3.64 | 10.19 | 17.44 | 13.76 | 14.02 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 1.46 | 5.47 | 9.26 | - | 13.79 | |||||
Gross Profit, 3 Yr. CAGR % | 0.76 | 4.2 | 6.66 | - | 14.93 | |||||
EBITDA, 3 Yr. CAGR % | 0.29 | 5.99 | 5.42 | - | 11.91 | |||||
EBITA, 3 Yr. CAGR % | -3.38 | 4.1 | 2.93 | - | 20.62 | |||||
EBIT, 3 Yr. CAGR % | -3.38 | 4.1 | 2.93 | - | 16.41 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -5.4 | 3.85 | 1.65 | - | 9.62 | |||||
Net Income, 3 Yr. CAGR % | -5.41 | 3.77 | 1.58 | - | 9.62 | |||||
Normalized Net Income, 3 Yr. CAGR % | -3.12 | 4.13 | 3.45 | - | 16.23 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -5.51 | 3.8 | 1.84 | - | 10.41 | |||||
Accounts Receivable, 3 Yr. CAGR % | 1.98 | 1.92 | 4.57 | - | 7.42 | |||||
Inventory, 3 Yr. CAGR % | 16.14 | 13.97 | 19.26 | - | 14.03 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 18.7 | 18.24 | 11.94 | - | 8.89 | |||||
Total Assets, 3 Yr. CAGR % | 7.79 | 9.55 | 8.88 | - | 7.45 | |||||
Tangible Book Value, 3 Yr. CAGR % | 52.9 | 29.49 | 25 | - | 20.98 | |||||
Common Equity, 3 Yr. CAGR % | 15.9 | 13.19 | 13.75 | - | 10.57 | |||||
Cash From Operations, 3 Yr. CAGR % | 1.98 | 14.77 | 0.02 | - | 14.22 | |||||
Capital Expenditures, 3 Yr. CAGR % | 25.05 | 10.82 | -5.44 | - | 8.64 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -54.34 | 2.65 | -1.4 | - | - | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -52.11 | 2.3 | -1.09 | - | - | |||||
Dividend Per Share, 3 Yr. CAGR % | 5.07 | 7.99 | 12.62 | - | 15.21 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 3.18 | 6.47 | 6.89 | - | - | |||||
Gross Profit, 5 Yr. CAGR % | 2.77 | 5.85 | 5.5 | - | - | |||||
EBITDA, 5 Yr. CAGR % | 3.68 | 7.55 | 4.83 | - | - | |||||
EBITA, 5 Yr. CAGR % | 1 | 6.11 | 2.09 | - | - | |||||
EBIT, 5 Yr. CAGR % | 3.59 | 9.1 | 2.09 | - | - | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 8.8 | 10.42 | -0.41 | - | - | |||||
Net Income, 5 Yr. CAGR % | 8.8 | 10.37 | -0.44 | - | - | |||||
Normalized Net Income, 5 Yr. CAGR % | 6.07 | 10.87 | 2.12 | - | - | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 10.08 | 10.89 | -0.35 | - | - | |||||
Accounts Receivable, 5 Yr. CAGR % | 4.56 | 4.7 | 4.41 | - | - | |||||
Inventory, 5 Yr. CAGR % | 12.73 | 13.22 | 17.37 | - | - | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 11.26 | 12.76 | 15.66 | - | - | |||||
Total Assets, 5 Yr. CAGR % | 8.43 | 7.61 | 8.23 | - | - | |||||
Tangible Book Value, 5 Yr. CAGR % | 11.74 | 70.3 | 39.7 | - | - | |||||
Common Equity, 5 Yr. CAGR % | 10.87 | 15.64 | 15.09 | - | - | |||||
Cash From Operations, 5 Yr. CAGR % | 8.63 | 11.84 | 0.51 | - | - | |||||
Capital Expenditures, 5 Yr. CAGR % | 17.18 | 12.39 | 10.58 | - | - | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -32.28 | -6.4 | -19 | - | - | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -30.35 | -6.14 | -18.47 | - | - | |||||
Dividend Per Share, 5 Yr. CAGR % | 8.26 | 10.12 | 9.86 | - | - |
- Stock Market
- Equities
- 4543 Stock
- Financials Terumo Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















